{"entity":{"type":"insider","cik":"0001855655","url":"/insider/0001855655","json_url":"/insider/0001855655.json","name":"Paradigm Biocapital Advisors LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":2,"first":"2023-12-08","last":"2024-08-05","span_basis":"filed_date"},"name_variants":[{"name":"Paradigm Biocapital Advisors LP","source":"filing","n_filings":2,"first_seen":"2023-12-08","last_seen":"2024-08-05"}],"transactions":[{"id":2076334,"accession":"0001104659-24-085835","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-085835","line_url":"/filing/0001104659-24-085835#line-2","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":null,"owner_name":"Paradigm Biocapital Advisors LP; Paradigm BioCapital Advisors GP LLC; Paradigm BioCapital International Fund Ltd.; Asefaw Senai","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1870499.0,"shares_display":"1,870,499","price_per_share":14.915,"price_display":"14.92","price_state":"stated","total_value":27898492.585,"total_display":"27,898,492.58","shares_owned_after":4720482.0,"shares_owned_after_display":"4,720,482","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-01","filed_date":"2024-08-05","scope":"insider"},{"id":2076332,"accession":"0001104659-24-085835","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-085835","line_url":"/filing/0001104659-24-085835#line-1","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":null,"owner_name":"Paradigm Biocapital Advisors LP; Paradigm BioCapital Advisors GP LLC; Paradigm BioCapital International Fund Ltd.; Asefaw Senai","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":529501.0,"shares_display":"529,501","price_per_share":14.915,"price_display":"14.92","price_state":"stated","total_value":7897507.415,"total_display":"7,897,507.42","shares_owned_after":783118.0,"shares_owned_after_display":"783,118","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-01","filed_date":"2024-08-05","scope":"insider"},{"id":8290870,"accession":"0001104659-23-124717","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-124717","line_url":"/filing/0001104659-23-124717#line-1","is_derivative":false,"issuer_cik":"0001750284","issuer_name":"Olema Pharmaceuticals, Inc.","issuer_ticker":"OLMA","issuer_name_source":null,"issuer_url":"/issuer/0001750284","owner_cik":null,"owner_name":"Paradigm BioCapital Advisors GP LLC; Paradigm BioCapital International Fund Ltd.; Asefaw Senai; Paradigm Biocapital Advisors LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":11.6,"price_display":"11.60","price_state":"stated","total_value":1160000.0,"total_display":"1,160,000.00","shares_owned_after":6590981.0,"shares_owned_after_display":"6,590,981","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-06","filed_date":"2023-12-08","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001750284","name":"Olema Pharmaceuticals, Inc.","url":"/issuer/0001750284","role":"Ten percent owner","n_filings":2,"first_seen":"2023-12-08","last_seen":"2024-08-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001855655","retrieved_at":"2026-08-21T17:39:59+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}